文献速递睡眠呼吸障碍肺栓塞与肺血管病

持续气道正压治疗依从性与睡眠呼吸暂停患者死亡及心血管事件的关系

Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究基于法国Pays de la Loire队列的真实世界数据,评估阻塞性睡眠呼吸暂停(OSA)患者持续气道正压(PAP)使用时长与主要不良心血管事件(MACE)的关联。中位随访6.6年,5138例患者中961例发生MACE;以0-4小时/晚为参照,6-7小时/晚组和≥7小时/晚组的调整风险比分别为0.75(95%CI 0.62-0.92)和0.78(95%CI 0.65-0.93),呈剂量-反应关系。

要点

  • PAP使用时长与MACE风险呈剂量-反应关系,6-7小时/晚获益最明显。
  • 男性、诊断时无明确心血管疾病者及过度嗜睡亚型中关联更强。
  • 真实世界数据支持提高PAP依从性以改善心血管结局。

核心结论

  • 真实世界数据显示PAP依从性与OSA患者新发MACE存在剂量-反应关系。

研究设计与样本

  • 基于Pays de la Loire队列与健康行政数据链接的回顾性队列研究,纳入5138例接受PAP处方的OSA患者,中位随访6.6年。

主要发现

  • 以0-4小时/晚为参照,4-6小时/晚组调整HR为0.87(95%CI 0.73-1.04),6-7小时/晚组为0.75(95%CI 0.62-0.92),≥7小时/晚组为0.78(95%CI 0.65-0.93),P=0.0130。
  • 男性患者交互作用P=0.0004,诊断时无明确心血管疾病者P<0.0001,过度嗜睡亚型P=0.060。

临床怎么用

  • 临床应关注并支持OSA患者提高PAP使用时长,以可能降低MACE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP) therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient selection and low PAP adherence preclude the generalization of their data to clinical samples. Objectives: To evaluate the association between hours of PAP use, mortality, and CV morbidity in real-life conditions. Methods: Data from the Pays de la Loire Cohort were linked to health administrative data to identify incident major adverse cardiovascular events (MACEs; a composite outcome of mortality, stroke, and cardiac diseases) in patients with OSA who were prescribed PAP. Cox proportional hazards analyses were conducted to evaluate the association between MACEs and quartiles of average daily PAP use over the study period. Measurements and Main Results: After a median follow-up of 6.6 years, 961 of 5,138 patients experienced MACEs. Considering nonadherent patients (0-4 h/night) as the reference group, adjusted hazard ratios (95% confidence intervals) for MACEs were 0.87 (0.73-1.04) for the 4-6 h/night group, 0.75 (0.62-0.92) for the 6-7 h/night group, and 0.78 (0.65-0.93) for the ⩾7 h/night group (P = 0.0130). Sensitivity analyses using causal inference approaches confirmed the association of PAP use with MACEs. The association was stronger in male patients (P value for interaction = 0.0004), patients without overt CV disease at diagnosis (P < 0.0001), and those belonging to the excessively sleepy symptom subtype (P = 0.060). Conclusions: These real-life clinical data demonstrate a dose-response relationship between PAP adherence and incident MACEs in OSA. Patient support programs may help improve PAP adherence and CV outcomes in patients with OSA.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Gervès-Pinquié C, Bailly S, Goupil F, et al. Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea. Am J Respir Crit Care Med. 2022. PMID: 35816570. doi:10.1164/rccm.202202-0366OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。